Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.
about
Suppression of innate inflammation and immunity by interleukin-37.IL-37 a New IL-1 Family Member Emerges as a Key Suppressor of Asthma Mediated by Mast Cells.The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice.Potential therapeutic use of IL-37: a key suppressor of innate immunity and allergic immune responses mediated by mast cells.SOCS molecules: the growing players in macrophage polarization and function.Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure.Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance.The potential of interleukin-37 as an effective therapeutic agent in asthma.Ethanol-mediated suppression of IL-37 licenses alcoholic liver disease.Suppression of inflammation and acquired immunity by IL-37.Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints.Interleukin-37 suppresses the inflammatory response to protect cardiac function in old endotoxemic mice.Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.Treating Heart Inflammation With Interleukin-1 Blockade in a Case of Erdheim-Chester Disease.Anakinra Therapy for Non-cancer Inflammatory Diseases
P2860
Q37213297-DEF5F0FA-7D3F-445A-96D7-ABD0E6AE25A5Q39041187-726D16E1-C3F8-4BE6-A1DE-A1836D754C19Q40100484-DC6154E0-0435-4EEC-8FDA-939646A51E0FQ40117785-ECD4AA34-5E7A-4477-B978-508422CE0915Q41694057-80630664-2667-487F-8B4C-6FFB3597E1E9Q41785739-59BCA3F9-07F5-4FAB-A94C-24E88AB54EE7Q42318107-6F1F03A4-AC11-44C7-8D71-1302153269FDQ47120024-8FD0ACB5-8CA5-46F3-B918-3E4ECF233F29Q48047569-CAAB33CD-48D1-41F8-A078-4F102B1A4CE5Q48105627-CAB06C37-8AC1-4261-8B5B-A7B7C4A0E98CQ50099588-753FD025-2DE4-4A6D-B1BA-76FA19B87265Q51122304-F99463BD-7456-4C41-AB35-696D020C9628Q52642372-7CD6C824-3D6E-4C53-B867-FEF11460599CQ55360198-31AF863B-E1FA-485A-8187-679B5187FD65Q59136398-C7F23D85-5A1A-49AD-96F4-F6510A37F24D
P2860
Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treating experimental arthriti ...... int and systemic inflammation.
@en
type
label
Treating experimental arthriti ...... int and systemic inflammation.
@en
prefLabel
Treating experimental arthriti ...... int and systemic inflammation.
@en
P2093
P2860
P50
P356
P1433
P1476
Treating experimental arthriti ...... int and systemic inflammation.
@en
P2093
Aik Choon Tan
Leo A B Joosten
Lorenzo Dagna
Marije Koenders
Vassili Kalabokis
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEW325
P577
2016-08-26T00:00:00Z